Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel peptide interacting with anti-apoptotic proteins of a bcl-2 family

An anti-apoptotic protein, bcl-2 technology, applied in the field of new peptides, can solve problems such as false negatives and false positives

Inactive Publication Date: 2012-10-10
LES LAB SERVIER +1
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, these traditional methods have their limitations
It is well known, for example, that these screening methods can cause false positives and / or false negatives, whereby biochemical confirmation of the obtained results is required

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel peptide interacting with anti-apoptotic proteins of a bcl-2 family
  • Novel peptide interacting with anti-apoptotic proteins of a bcl-2 family
  • Novel peptide interacting with anti-apoptotic proteins of a bcl-2 family

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0059] Example 1: Identification of the peptide described in SEQ.ID.NO.1

[0060] The conjugation protocol was utilized in yeast (Legrain et al., Nature Genetics, 1997, 16 , 277-282) were screened against three human cDNA libraries (placental, brain, cell line CEMC7) by the double-hybrid technique (Fields et al.).

[0061] 1) Preparation of "bait" and "capture" proteins

[0062] a) The "bait" used is:

[0063] - Bcl-XL(1-209) C-terminal truncation fused to the LexA DNA binding domain

[0064] - Bcl-2(1-211) C-terminal truncation fused to the LexA DNA binding domain

[0065] - Bcl-XL (1-209) C-terminal truncation fused to the LexA DNA binding domain

[0066] They were expressed in Saccharomyces cerevisiae (CG1945 or L40ΔGal4) and pre-cultured at 30°C in synthetic medium lacking tryptophan (DO-Trp) until DO 600nm Achieving between 0.1 and 0.5 inclusive. Dilute 50ml of the preculture (DO 600nm =0.006) and incubated overnight at 30°C.

[0067] b) Yeast pools containing...

Embodiment 2

[0080] Example 2: Comparison between the peptides described in Example 1 and Bcl-W and / or Bcl-XL and / or Bcl-2

[0081] Identification of interactions

[0082] 1) GST "settlement"

[0083] The peptide obtained from Example 1 and Interaction between Bcl-W and / or Bcl-XL and / or Bcl-2.

[0084] a) Synthesis of radiolabeled Bid

[0085] Labeled proteins were obtained using TNT quick master kit (Promega). Mix 40 μl of TNT mix with 2 μl (equivalent to 20 μCi) 35 S-methionine (Amersham), 1 μg of plasmid DNA encoding Bid and sufficient water to bring the volume to 50 μl were incubated at 30° C. for 90 minutes.

[0086] The number of fmoles / μl of radioactive protein produced was calculated based on the number of methionines in the protein.

[0087] b) GST "settlement"

[0088] Combine 4 fmole of radioactive Bid protein with 3 μg fusion protein glutathione-S-transferase-Bcl-XL (GST-Bcl-XL) or glutathione-S-transferase-Bcl-2 (GST-Bcl-2 ) or glutathione-S-transferase-Bcl-W...

Embodiment 3

[0098] Embodiment 3: can inhibit Bcl-W and / or Bcl-XL and / or Bcl-2 and obtain in embodiment 1 Screening Assays for Compounds Interacting Between Peptides

[0099]Compounds to be tested were dispensed into 384-well plates (Corning flat bottom) at a final concentration of 10 μg / ml. As a control, fill one well with an equal volume of buffer / solvent without the compound to be tested. The peptide obtained in Example 1 labeled with fluorescein was added to each well so as to give a final concentration of 15 nM. Then add the fusion protein GST-Bcl-XL, GST-Bcl-W or GST-Bcl-2, so that in the 2 HPO 4 A final concentration of 500 nM (Bcl-XL, Bcl-2) and 1 μM (Bcl-W) was obtained in a buffer of 20 mM pH 4, EDTA 1 mM, NaCl 50 mM and pluronic acid F-68 0.05%. Fluorescence polarization was then measured by an En indicator (Packard Perkin-Elmer). A significant decrease in the fluorescence polarization recorded in experiments performed with the test compound compared to that obtained wi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the identification of a new peptide interacting with the anti-apoptotic proteins Bcl-2, Bcl-W and / or Bcl-XL, and also to screening methods allowing identification of modifiers of those interactions.

Description

technical field [0001] The present invention relates to novel peptides that interact with Bcl-XL and / or Bcl-2 and / or Bcl-W, and also to screening methods that allow the identification of compounds capable of modulating this interaction. Background of the invention [0002] Most biological processes involve protein-protein interactions. One of the setting goals of proteomics is to map these interactions. Because of their involvement in most signaling mechanisms, these interactions are preferred targets in drug development. [0003] A number of methodologies exist to enable the identification of protein interactions. One of the most common is the two-hybrid system originally described and developed by Fields et al. (US 5,283,173; US 5,468,614; US 5,667,973). [0004] This system basically consists of an in vitro test between two recombinant proteins. The first of these, often referred to as "bait" proteins, are chimeric proteins fused to a DNA-binding domain (BD) capable o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/47G01N33/50C12N15/12
CPCC07K14/4702C07K14/4747A61P25/00A61P35/00A61P37/06A61P43/00
Inventor O·热内斯特J·希克曼R·贝内特J-C·雷恩
Owner LES LAB SERVIER